Albendazole 200mg (30s)

Albendazole is a broad-spectrum antiparasitic medication that effectively eliminates intestinal worms by inhibiting microtubule formation in parasites. Emerging research also highlights its anti-cancer potential through microtubule disruption, inducing apoptosis in tumor cells and inhibiting cancer cell proliferation

Directions for Use:

• Research Purposes Only: This product is intended solely for research applications.
• Handling Precautions: All chemical compounds carry inherent risks. It is essential to review available research and understand the associated hazards before handling.
• Uncertain Handling Methods: If you are unsure about proper handling procedures, please contact the supplier for guidance.
• Misuse Warning: Improper use of this product may lead to adverse reactions.
• Storage Instructions: Store at room temperature in a tightly sealed container, away from heat, light, and moisture.
• Keep Away from Children: Ensure this product is inaccessible to children.
• Regulatory Status: This product is not approved by the South African Health Products Regulatory Authority (SAHPRA)

  What is Albendazole?

  Albendazole is a well-established antiparasitic medication now gaining recognition for its emerging role in cancer therapy. Traditionally used to treat parasitic worm infections, Albendazole works by inhibiting microtubule synthesis, effectively disrupting cell division in parasites—and, as recent studies reveal, in cancer cells too. This dual-action capability makes it a fascinating candidate in the field of oncology, especially for its potential in targeting resistant cancer types.

  What makes Albendzazole unique?

  What sets Albendazole apart is its unique mechanism of action that interferes with cancer cell proliferation and angiogenesis—the process by which tumors form new blood vessels. Its affordability, accessibility, and established safety profile make it a promising adjunct or alternative treatment pathway in ongoing cancer research and compassionate use therapies. Albendazole exemplifies how innovation can arise from reimagining existing science.

  Key benefits:

  • Disrupts cancer cell division through microtubule inhibition
  • Demonstrates anti-angiogenic effects to restrict tumor growth
  • Potential to complement existing chemotherapy treatments
  • Established safety record and cost-effective accessibility
  • Ongoing research supports its role in various cancer types